Cylex Announces Plan For Multi-Center Trial Of ImmuKnow(R) Assay In South Korea
admin “Cylex, Inc., in connexion with our Asiatic distributor, Sun Woo Biotech, is delighted to be healthy to foretell our hold for a major, multi-center effort of the ImmuKnow assessment for cell-mediated status at heptad highly reputable scrutiny institutions in the Republic of Korea,” expressed Brad Stewart, chair of Cylex.
Tags: Institutions
Posted in Immunology |